Hematopoietic SH2 Domain Containing (HSH2D) (C-Term) Peptide
Quick Overview for Hematopoietic SH2 Domain Containing (HSH2D) (C-Term) Peptide (ABIN8102321)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- HSH2D Peptide - C-terminal region
-
Sequence
- DPCVATSLKS PSQPQAPKDR KVPTRKAERS VSCIEVTPGD RSWHQMVVRA
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-HSH2D Antibody (ARP60697_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
-
Background
-
Background Information: T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
Alternative Symbols: ALX, FLJ14886, HSH2
-
Molecular Weight
- 39kDa
-
Gene ID
- 84941
-
NCBI Accession
- NP_116244
-
UniProt
- Q96JZ2
Target
-